DIA Biosimilars 2013

Hybrigenics

European collaborative research project AgedBrainSYSBIO launches

Wednesday, April 3, 2013 09:20 AM

The AgedBrainSYSBIO project on systems biology of synapse proteins and aging was officially launched March 18 in Paris. The European collaborative research project is funded by the European Commission under the Health Work Program of the Seventh Framework Program.

More... »

Cenduit: Now with Patient Reminders

Hybrigenics, Servier ink license and research agreement

Tuesday, October 11, 2011 11:38 AM

Hybrigenics and Servier have signed a license and research collaboration agreement in the field of deubiquitinating enzymes (DUBs) applied to oncology, neurology, psychiatry, rheumatology, ophthalmology, diabetes and cardiovascular diseases.

More... »

CRF Health – eCOA Forum

Hybrigenics names Munoz to its board of directors

Thursday, October 6, 2011 10:39 AM

Hybrigenics has named Dr. Alain Munoz to its board as a non-executive independent director. Munoz replaces Dr. Bernhard Ehmer, president of ImClone Systems, and will chair the clinical advisory board.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs